<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Limited has submitted a disclosure to BSE confirming that, as on March 31, 2025, the company does not qualify as a 'Large Corporate' under the SEBI Circular dated November 26, 2018. This circular requires companies classified as Large Corporates to raise at least 25% of their incremental borrowings through debt securities listed on a recognised stock exchange. By confirming non-applicability, the company states it falls below the prescribed thresholds and therefore is exempt from these mandatory debt-security fundraising obligations. The disclosure is signed by Director Ashok Somani (DIN: 03063364) and is dated April 16, 2025.
This is a routine compliance filing with no material effect on shareholders or the stock price. It simply clarifies that the company is below the Large Corporate size threshold and is therefore not required to meet the SEBI-mandated minimum debt-securities fundraising ratio.